Imprimis Pharmaceuticals Licenses IP
socalTECH
JUNE 17, 2013
Imprimis said it is in the process of filing for a patent on those new IP assets. imprimis pharmaceuticals lifescience merger acquisition pharma buderer' Imprimis said it is developing innovations based on technology from the compounding pharmacy operations of Buderer. READ MORE>>.
Let's personalize your content